In conclusion, to our knowledge, to date, the present study of SEER data collected over 25 years represents the most comprehensive clinical analysis of AFP levels and reveals that the AFP level is an independent risk factor associated with pathological grade, progression, and survival of patients with HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.